157 related articles for article (PubMed ID: 19744737)
1. Reverse resistance to radiation in KYSE-150R esophageal carcinoma cell after epidermal growth factor receptor signal pathway inhibition by cetuximab.
Jing Z; Gong L; Xie CY; Zhang L; Su HF; Deng X; Wu SX
Radiother Oncol; 2009 Dec; 93(3):468-73. PubMed ID: 19744737
[TBL] [Abstract][Full Text] [Related]
2. Bmi-1 confers adaptive radioresistance to KYSE-150R esophageal carcinoma cells.
Wang G; Liu L; Sharma S; Liu H; Yang W; Sun X; Dong Q
Biochem Biophys Res Commun; 2012 Aug; 425(2):309-14. PubMed ID: 22842564
[TBL] [Abstract][Full Text] [Related]
3. FH535 increases the radiosensitivity and reverses epithelial-to-mesenchymal transition of radioresistant esophageal cancer cell line KYSE-150R.
Su H; Jin X; Zhang X; Zhao L; Lin B; Li L; Fei Z; Shen L; Fang Y; Pan H; Xie C
J Transl Med; 2015 Mar; 13():104. PubMed ID: 25888911
[TBL] [Abstract][Full Text] [Related]
4. HDAC inhibitors reverse acquired radio resistance of KYSE-150R esophageal carcinoma cells by modulating Bmi-1 expression.
Dong Q; Sharma S; Liu H; Chen L; Gu B; Sun X; Wang G
Toxicol Lett; 2014 Jan; 224(1):121-9. PubMed ID: 24459703
[TBL] [Abstract][Full Text] [Related]
5. Mechanisms of enhanced radiation response following epidermal growth factor receptor signaling inhibition by erlotinib (Tarceva).
Chinnaiyan P; Huang S; Vallabhaneni G; Armstrong E; Varambally S; Tomlins SA; Chinnaiyan AM; Harari PM
Cancer Res; 2005 Apr; 65(8):3328-35. PubMed ID: 15833866
[TBL] [Abstract][Full Text] [Related]
6. Inhibition of cyclin D1 enhances sensitivity to radiotherapy and reverses epithelial to mesenchymal transition for esophageal cancer cells.
Su H; Jin X; Shen L; Fang Y; Fei Z; Zhang X; Xie C; Chen X
Tumour Biol; 2016 Apr; 37(4):5355-63. PubMed ID: 26561473
[TBL] [Abstract][Full Text] [Related]
7. Radiobiological characteristics of cancer stem cells from esophageal cancer cell lines.
Wang JL; Yu JP; Sun ZQ; Sun SP
World J Gastroenterol; 2014 Dec; 20(48):18296-305. PubMed ID: 25561796
[TBL] [Abstract][Full Text] [Related]
8. Identification of microRNAs involved in the radioresistance of esophageal cancer cells.
Su H; Jin X; Zhang X; Xue S; Deng X; Shen L; Fang Y; Xie C
Cell Biol Int; 2014 Mar; 38(3):318-25. PubMed ID: 24155113
[TBL] [Abstract][Full Text] [Related]
9. Nimotuzumab abrogates acquired radioresistance of KYSE-150R esophageal cancer cells by inhibiting EGFR signaling and cellular DNA repair.
Liu H; Yang W; Gao H; Jiang T; Gu B; Dong Q; Xu W; Wu S; Sun X
Onco Targets Ther; 2015; 8():509-18. PubMed ID: 25750543
[TBL] [Abstract][Full Text] [Related]
10. Improvement of esophageal adenocarcinoma cell and xenograft responses to radiation by targeting cyclin-dependent kinases.
Raju U; Ariga H; Koto M; Lu X; Pickett J; Valdecanas D; Mason KA; Milas L
Radiother Oncol; 2006 Aug; 80(2):185-91. PubMed ID: 16905211
[TBL] [Abstract][Full Text] [Related]
11. Fractionated irradiation-induced EMT-like phenotype conferred radioresistance in esophageal squamous cell carcinoma.
Zhang H; Luo H; Jiang Z; Yue J; Hou Q; Xie R; Wu S
J Radiat Res; 2016 Jul; 57(4):370-80. PubMed ID: 27125498
[TBL] [Abstract][Full Text] [Related]
12. Modulation of radiation response after epidermal growth factor receptor blockade in squamous cell carcinomas: inhibition of damage repair, cell cycle kinetics, and tumor angiogenesis.
Huang SM; Harari PM
Clin Cancer Res; 2000 Jun; 6(6):2166-74. PubMed ID: 10873065
[TBL] [Abstract][Full Text] [Related]
13. Intracytoplasmic epidermal growth factor receptor shows poor response to the cetuximab antitumor effect in irradiated non-small cell lung cancer cell lines.
Ryu SH; Lee SW; Yang YJ; Song SY; Kim JH; Choi EK; Ahn SD
Lung Cancer; 2012 Sep; 77(3):482-7. PubMed ID: 22704525
[TBL] [Abstract][Full Text] [Related]
14. CircRNA_100367 regulated the radiation sensitivity of esophageal squamous cell carcinomas through miR-217/Wnt3 pathway.
Liu J; Xue N; Guo Y; Niu K; Gao L; Zhang S; Gu H; Wang X; Zhao D; Fan R
Aging (Albany NY); 2019 Dec; 11(24):12412-12427. PubMed ID: 31851619
[TBL] [Abstract][Full Text] [Related]
15. Cytotoxic properties of radionuclide-conjugated Cetuximab without and in combination with external irradiation in head and neck cancer cells in vitro.
Eke I; Ingargiola M; Förster C; Kunz-Schughart LA; Baumann M; Runge R; Freudenberg R; Kotzerke J; Heldt JM; Pietzsch HJ; Steinbach J; Cordes N
Int J Radiat Biol; 2014 Aug; 90(8):678-86. PubMed ID: 24597752
[TBL] [Abstract][Full Text] [Related]
16. Pingyangmycin downregulates the expression of EGFR and enhances the effects of cetuximab on esophageal cancer cells and the xenograft in athymic mice.
Gong JH; Liu XJ; Li Y; Zhen YS
Cancer Chemother Pharmacol; 2012 May; 69(5):1323-32. PubMed ID: 22311160
[TBL] [Abstract][Full Text] [Related]
17. Cetuximab attenuates its cytotoxic and radiosensitizing potential by inducing fibronectin biosynthesis.
Eke I; Storch K; Krause M; Cordes N
Cancer Res; 2013 Oct; 73(19):5869-79. PubMed ID: 23950208
[TBL] [Abstract][Full Text] [Related]
18. Cytotoxicity and radiosensitization effect of TRA-8 on radioresistant human larynx squamous carcinoma cells.
Wu F; Hu Y; Long J; Zhou YJ; Zhong YH; Liao ZK; Liu SQ; Zhou FX; Zhou YF; Xie CH
Oncol Rep; 2009 Feb; 21(2):461-5. PubMed ID: 19148523
[TBL] [Abstract][Full Text] [Related]
19. Inhibition of EGFR or IGF-1R signaling enhances radiation response in head and neck cancer models but concurrent inhibition has no added benefit.
Raju U; Molkentine DP; Valdecanas DR; Deorukhkar A; Mason KA; Buchholz TA; Meyn RE; Ang KK; Skinner H
Cancer Med; 2015 Jan; 4(1):65-74. PubMed ID: 25355701
[TBL] [Abstract][Full Text] [Related]
20. Inhibition of STAT-3 results in greater cetuximab sensitivity in head and neck squamous cell carcinoma.
Bonner JA; Yang ES; Trummell HQ; Nowsheen S; Willey CD; Raisch KP
Radiother Oncol; 2011 Jun; 99(3):339-43. PubMed ID: 21704410
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
